MA53021A - Composition de diacide oligosaccharidique d'alginate - Google Patents

Composition de diacide oligosaccharidique d'alginate

Info

Publication number
MA53021A
MA53021A MA053021A MA53021A MA53021A MA 53021 A MA53021 A MA 53021A MA 053021 A MA053021 A MA 053021A MA 53021 A MA53021 A MA 53021A MA 53021 A MA53021 A MA 53021A
Authority
MA
Morocco
Prior art keywords
oligosaccharidique
diacid
alginate
composition
diacid oligosaccharidique
Prior art date
Application number
MA053021A
Other languages
English (en)
Inventor
Jian Ding
Meiyu Geng
Yingshen Jin
Zhongping Xiao
Zhenqing Zhang
Original Assignee
Shanghai Green Valley Pharmaceutical Co Ltd
Shanghai Inst Materia Medica Cas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Green Valley Pharmaceutical Co Ltd, Shanghai Inst Materia Medica Cas filed Critical Shanghai Green Valley Pharmaceutical Co Ltd
Publication of MA53021A publication Critical patent/MA53021A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
MA053021A 2018-06-29 2019-06-28 Composition de diacide oligosaccharidique d'alginate MA53021A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810721327.6A CN110652517A (zh) 2018-06-29 2018-06-29 褐藻胶寡糖二酸的组合物

Publications (1)

Publication Number Publication Date
MA53021A true MA53021A (fr) 2021-05-05

Family

ID=68984639

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053021A MA53021A (fr) 2018-06-29 2019-06-28 Composition de diacide oligosaccharidique d'alginate

Country Status (15)

Country Link
US (1) US11464794B2 (fr)
EP (1) EP3815692A4 (fr)
JP (1) JP7672226B2 (fr)
KR (1) KR20210041556A (fr)
CN (1) CN110652517A (fr)
AU (1) AU2019296843C1 (fr)
BR (1) BR112020026849A2 (fr)
CA (1) CA3104959A1 (fr)
EA (1) EA202190080A1 (fr)
MA (1) MA53021A (fr)
MY (1) MY208187A (fr)
PH (1) PH12020552287A1 (fr)
UA (1) UA129182C2 (fr)
WO (1) WO2020001632A1 (fr)
ZA (1) ZA202100350B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336742A (zh) * 2019-08-06 2021-02-09 上海绿谷制药有限公司 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途
CN112741838A (zh) * 2019-10-31 2021-05-04 上海绿谷制药有限公司 含有褐藻胶寡糖二酸的药用组合物
CN114588171A (zh) * 2022-04-24 2022-06-07 中国海洋大学 褐藻胶低聚糖在制备预防和/或治疗炎症所致肠黏膜o-糖链结构异常疾病产品中的应用
CN114874351B (zh) * 2022-05-19 2023-06-16 青岛海洋生物医药研究院股份有限公司 一种褐藻胶寡糖-纳米银配合物及其制方法和应用
CN115005447B (zh) * 2022-06-16 2024-02-06 青岛海关技术中心 低聚古罗糖醛酸在制备抗疲劳产品中的应用
CN116688222B (zh) * 2023-06-27 2024-05-07 暨南大学附属第一医院（广州华侨医院） 一种基于乏氧外泌体的智能响应水凝胶敷料及其制备方法和应用
WO2025245773A1 (fr) * 2024-05-30 2025-12-04 海糖（江苏）生物医药科技有限公司 Dérivé d'oligosaccharide de fucoïdane, son procédé de préparation et son utilisation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100508985C (zh) * 2004-03-24 2009-07-08 中国海洋大学 褐藻胶寡糖及其衍生物及其制备方法和用途
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
WO2007069468A1 (fr) * 2005-12-14 2007-06-21 Nagasaki University Promoteur de secretion de cytokine
JP2016108474A (ja) * 2014-12-08 2016-06-20 栄治 松村 オリゴ糖の製造方法およびオリゴ糖
CN104892792B (zh) 2015-05-22 2018-08-24 上海绿谷制药有限公司 一种氧化型α-1,4-寡聚葡萄糖醛酸及其制备方法和用途
CN106344592A (zh) * 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用
CN106344593B (zh) 2015-07-17 2020-01-10 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用
CN106344595B (zh) * 2015-07-17 2020-06-19 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用
CN106344594A (zh) 2015-07-17 2017-01-25 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在治疗炎症中的应用
DE102016113018A1 (de) * 2016-07-14 2018-01-18 Abbas Mirshafiey Pharmazeutische Verwendung von beta-D-Mannuronsäure
KR20190046871A (ko) * 2016-08-15 2019-05-07 상하이 그린벨리 파머수티컬 주식회사 올리고만누론 이산의 제조방법
MY192462A (en) * 2016-12-30 2022-08-22 Shanghai Inst Materia Medica Cas Composition of mannuronic dicarboxylic acid

Also Published As

Publication number Publication date
AU2019296843C1 (en) 2025-04-17
EP3815692A1 (fr) 2021-05-05
CN110652517A (zh) 2020-01-07
US11464794B2 (en) 2022-10-11
BR112020026849A2 (pt) 2021-04-06
US20210260085A1 (en) 2021-08-26
KR20210041556A (ko) 2021-04-15
AU2019296843A1 (en) 2021-01-28
ZA202100350B (en) 2023-06-28
AU2019296843B2 (en) 2024-12-12
PH12020552287A1 (en) 2021-06-21
EA202190080A1 (ru) 2021-07-20
JP7672226B2 (ja) 2025-05-07
MY208187A (en) 2025-04-22
EP3815692A4 (fr) 2022-04-13
WO2020001632A1 (fr) 2020-01-02
CA3104959A1 (fr) 2020-01-02
JP2021529197A (ja) 2021-10-28
UA129182C2 (uk) 2025-02-05

Similar Documents

Publication Publication Date Title
MA53021A (fr) Composition de diacide oligosaccharidique d'alginate
MA49403A (fr) Compositions de pde5 et méthodes d'immunothérapie
EP3768854A4 (fr) Modulation de l'expression de hsd17b13
EP3589646A4 (fr) Compositions à base de cd19 et méthodes pour l'immunothérapie
EP3656821A4 (fr) Composition d'asphalte
EP3820490A4 (fr) Compositions d'aav
MA53924A (fr) Modulateurs de l'expression d'apol1
EP3661552A4 (fr) Compositions et méthodes d'inhibition de l'élimination de mica/b
EP3746058A4 (fr) Compositions et méthodes d'amélioration de la biodisponibilité de 5-hydroxytryptophane
EP3817750A4 (fr) Compositions d'associations de cannabidiol
EP3677848A4 (fr) Dispositif de réglage de composition d'air
EP3820980A4 (fr) Compositions d'esterquats
EP3739000A4 (fr) Composition de latex
EP3733177A4 (fr) Composition pour la protection de la cornée
EP3632453A4 (fr) Agent d'amélioration de la qualité musculaire
EP3733198A4 (fr) Composition pour la régénération de cartilage fibreux ou de cartilage élastique humain
EP3738999A4 (fr) Composition de latex
EP3950864A4 (fr) Composition d'apprêt
EP3938457A4 (fr) Composition d'enrobage thermoconductrice
EP3873986A4 (fr) Composition d'enrobage thermoconductrice
EP3718414A4 (fr) Composition d'émulsion
EP3616531A4 (fr) Composition d'émulsion
MA50547A (fr) Composés et compositions d'induction de la chondrogenèse
EP3582817C0 (fr) Échafaudage tissulaire et composition d'échafaudage
EP3846831A4 (fr) Compositions d'associations de probiotiques